Answer
It is unknown whether glycerol phenylbutyrate or its metabolites enter human breast milk; infant risk cannot be excluded, so a decision between stopping breast-feeding or stopping/avoiding therapy must consider the benefits of breast-feeding for the child and treatment for the woman.
Sources for this answer
- RAVICTI 1.1 g/ml oral liquidImmedica · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked